NCT05755347 Assessing Functional Status Needs Via PRO Measures for Pts With Metastatic Breast Cancer Status COMPLETED Phase N/A
NCT05755048 FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Status RECRUITING Phase PHASE3
NCT05754749 Comparison of CE-DBT and MRI in Patients With Known Breast Lesions Status RECRUITING Phase EARLY_PHASE1
NCT05754528 Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05754502 Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target Therapy Status UNKNOWN Phase N/A
NCT05754060 Cognitive Processing Slowness as a Marker of Cognitive Impairment in Non-central Nervous System Cancer Patients Status NOT_YET_RECRUITING Phase N/A
NCT05749575 Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer. Status UNKNOWN Phase PHASE2
NCT05748834 Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer Status RECRUITING Phase PHASE2
NCT05748353 Endocrine Disruptors and Life STILe in Breast Cancer Development Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05747326 Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer Status UNKNOWN Phase PHASE2
NCT05747313 Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT05744518 Monitoring Response to Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast DCE-MRI Status UNKNOWN Phase N/A
NCT05740956 A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT05739175 The Effect of the Mobile Application-based Support Program on the Outcomes of Breast Cancer Patients in the Pandemic Status COMPLETED Phase NA
NCT05738993 A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of a Single Intravenous Infusion of BCD-178 or Perjeta® in Healthy Volunteers Status UNKNOWN Phase PHASE1